ACTIVE

PHARMACERTO

Export PDF

Financial year 2025 · Closed on 30/09/2025

Net result
196 k €
+56,1 %over 1 year
Gross margin
512,4 k €
+15,7 %over 1 year
Equity
1,5 M €
+15,1 %over 1 year
Workforce
2,6 ETP
+30,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACERTO is a Private limited company incorporated in 2000. Its registered office is in Sint-Niklaas. It employs on average 2,6 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0471.562.629
Incorporation
30/03/2000
Legal form
Private limited company
Registered office
Dries 45
9112 Sint-Niklaas · FlandreSee on map
Contributed capital
6 200,00 €
Latest accounts
30/09/2025
Average workforce
2,6 ETP
Joint committees (1)
  • 313
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Gross margin512,4 k €443 k €374,8 k €437,9 k €402 k €
EBITDA288 k €270,4 k €204,9 k €275,2 k €234,6 k €
Operating result217,1 k €193,2 k €140,4 k €209,2 k €166,4 k €
Net result196 k €125,6 k €95 k €140,9 k €116,7 k €
Balance sheet
Equity1,5 M €1,3 M €1,2 M €1,1 M €932,5 k €
Total assets2,3 M €2,1 M €1,8 M €1,8 M €1,6 M €
Cash414,3 k €476,1 k €329,6 k €825,1 k €581 k €
Debts827,8 k €744,9 k €644,3 k €705,8 k €637 k €
Other
Workforce2,6 ETP2,0 ETP1,8 ETP2,1 ETP2,3 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 2 ended

Active mandates

Frederik Henri Magerman

Director

Active

Ended mandates

Frederik Magerman

Director

Ended
Frederik Magerman

Manager

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/10/202401/10/202301/10/202201/10/202101/10/202001/10/2019
Closing of the financial year30/09/202530/09/202430/09/202330/09/202230/09/202130/09/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date04/03/202629/04/202522/03/202430/03/202305/05/202213/04/2021
General meeting25/02/202624/02/202528/02/202422/02/202323/02/202224/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model30/09/202525/02/202604/03/2026DutchPDF
Abridged model30/09/202424/02/202529/04/2025DutchPDF
Abridged model30/09/202328/02/202422/03/2024DutchPDF
Abridged model30/09/202222/02/202330/03/2023DutchPDF
Abridged model30/09/202123/02/202205/05/2022DutchPDF
Abridged model30/09/202024/02/202113/04/2021DutchPDF
Abridged model30/09/201926/02/202027/02/2020DutchPDF
Abridged model30/09/201827/02/201928/02/2019DutchPDF
Abridged model30/09/201728/02/201802/03/2018DutchPDF
Abridged model30/09/201622/02/201723/02/2017DutchPDF
Abridged model30/09/201524/02/201625/02/2016DutchPDF
Abridged model30/09/201425/02/201526/02/2015DutchPDF
Abridged model30/09/201326/02/201427/02/2014DutchPDF
Abridged model30/09/201227/02/201322/03/2013DutchPDF
Abridged model30/09/201122/02/201223/02/2012DutchPDF
Abridged model30/09/201023/02/201124/02/2011DutchPDF
Abridged model30/09/200924/02/201025/02/2010DutchPDF
Abridged model30/09/200825/02/200926/02/2009DutchPDF
Abridged model30/09/200727/02/200829/02/2008DutchPDF
Abridged model30/09/200628/02/200727/03/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/09/2025

1 active · 2 ended

Active mandates

Frederik Henri Magerman

Director

Active

Ended mandates

Frederik Magerman

Director

Ended
Frederik Magerman

Manager

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates23/09/2020
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares24/09/2014
    KAPITAAL - AANDELEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025196 k €↑
  2. 2024
    Annual accounts 2024125,6 k €↑
  3. 2023
    Annual accounts 202395 k €↓
  4. 2022
    Annual accounts 2022140,9 k €↑
  5. 2021
    Annual accounts 2021116,7 k €↑
  6. 2020
    Annual accounts 202082,7 k €↓
  7. 2019
    Annual accounts 2019112,7 k €↑
  8. 2018
    Annual accounts 201873,9 k €↑
  9. 2017
    Annual accounts 201750,1 k €↓
  10. 2016
    Annual accounts 2016101,1 k €↓
  11. 2015
    Annual accounts 2015191,8 k €↑
  12. 2014
    Annual accounts 2014101,6 k €↑
  13. 2013
    Annual accounts 201393,5 k €↓
  14. 2012
    Annual accounts 2012103,6 k €↑
  15. 2011
    Annual accounts 201194,4 k €↑
  16. 2010
    Annual accounts 201088,6 k €↑
  17. 2009
    Annual accounts 200962,2 k €↓
  18. 2008
    Annual accounts 200870,2 k €↑
  19. 2007
    Annual accounts 200753,5 k €
  20. 30/03/2000
    IncorporationPrivate limited company